Abstract: Devices and methods related to endocardial acceleration signal processing are provided. One device is configured to: (1) divide an endocardial acceleration (EA) signal into a plurality of EA sub-signals; (2) identify, in each of the plurality of EA sub-signals, at least one signal component associated with a type of heart sound; (3) extract a characteristic of the at least one signal component for two or more of the plurality of cycles; (4) calculate a correlation coefficient correlating the at least signal component for a first cycle of the plurality of cycles to the at least one signal component of a second cycle of the plurality of cycles; and (5) perform temporal retiming of one or more of the signal components based on the correlation coefficient to generate one or more adjusted signal components of the associated one or more EA sub-signals.

Abstract: This document discusses, among other things, a system comprising a sensor signal processor configured to receive a plurality of electrical sensor signals produced by a plurality of sensors and at least one sensor signal produced by an implantable sensor, a memory that includes information indicating a co-morbidity of a subject, a sensor signal selection circuit that selects a sensor signal to monitor from among the plurality of sensor signals, according to an indicated co-morbidity, a threshold adjustment circuit that adjusts a detection threshold of the selected sensor signal according to the indicated co-morbidity, and a decision circuit that applies the adjusted detection threshold to the selected sensor signal to determine whether an event associated with worsening heart failure (HF) occurred in the subject and outputs an indication of whether the event associated with worsening HF occurred to a user or process.

Abstract: The invention relates to the field of technological assistance for anaesthesia and intensive care practitioners, as well as to the field of simple, reliable medical monitoring for managing anaesthesia and/or predicting deleterious medical events. The invention aims to provide a system enabling prevention and anticipation of procedures necessary for patients and/or maintenance of patients in a suitable anaesthetic state for a surgical operation at a given time. For this purpose, the invention provides a method of predicting abnormal medical events and/or assisting in diagnosis and/or monitoring, comprising the continuous, real-time detection of a concomitant occurrence of a temporary inefficiency in cardiac baroreceptor reflex and an activation of non-baroreceptor reflex cardiovascular control. The invention also relates to the device used to implement said method.

Abstract: A cardiac rhythm management system provides for ambulatory monitoring of hemodynamic performance based on quantitative measurements of heart sound related parameters for diagnostic and therapeutic purposes. Monitoring of such heart sound related parameters allows the cardiac rhythm management system to determine a need for delivering a therapy and/or therapy parameter adjustments based on conditions of a heart. This monitoring also allows a physician to observe or assess the hemodynamic performance for diagnosing and making therapeutic decisions. Because the conditions of the heart may fluctuate and may deteriorate significantly between physician visits, the ambulatory monitoring, performed on a continuous or periodic basis, ensures a prompt response by the cardiac rhythm management system that may save a life, prevent hospitalization, or prevent further deterioration of the heart.

Abstract: A medical device and associated method establish an occurrence of a premature atrial contraction. The device senses a ventricular signal. A control unit is configured to determine a metric of the ventricular signal during an interval following the premature atrial contraction and detect a change in cardiac stress tolerance in response to the determined metric.

Abstract: Systems and Methods for predicting patient health and patient relative well-being within a patient management system are disclosed. A preferred embodiment utilizes an implantable medical device comprising an analysis component and a sensing component further comprising a three-dimensional accelerometer, a transthoracic impedance sensor, a cardio-activity sensor, an oxygen saturation sensor and a blood glucose sensor. Some embodiments of a system disclosed herein also can be configured as an Advanced Patient Management System that helps better monitor, predict and manage chronic diseases.

Abstract: In an implantable heart monitoring device and a monitoring method, an impedance is measured across at least part of an atrium, such that variation of the impedance is related to the volume change of the atrium. Values are stored at different occasions that indicate the rate of change of the measured impedance. The stored values are determined such that, when the device is used in a living being, the variation of the stored values will be related to the variation of the speed with which the atrium is filled with blood during the atrial diastole.

Abstract: A computer-implemented electrocardiographic data processor with time stamp correlation is provided. A monitoring circuit includes a persistent memory and power supply that powers an encoder that determines a differential voltage between a current discrete digital voltage value and a prior voltage value. The differential voltage is stored into the persistent memory in a digitized data stream representative of analog cardiac action potential signals. Digitally-encoded voltage values and time stamps are retrieved from the persistent memory. A post-processing application executes. A set of output voltages and voltage differences that each correspond to lower and upper bounds of voltage is stored. Each retrieved voltage value is compared to the voltage bounds and the voltage differences within which each retrieved voltage value falls is identified. The output voltages corresponding to the voltage differences is selected.

Abstract: A medical device is provided that comprises a lead assembly. The lead assembly includes at least one intra-cardiac (IC) electrode, an extra-cardiac (EC) electrode and a subcutaneous remote-cardiac (RC) electrode. The IC electrode is configured to be located within the heart. The EC electrode is configured to be positioned proximate to at least one of a superior vena cava (SVC) and a left ventricle (LV) of a heart. The RC electrode is configured to be located remote from the heart. An extra-cardiac impedance (ECI) module is configured to measure extra-cardiac impedance along an ECI vector between the EC and RC electrodes to obtain ECI measurements. An arrhythmia monitoring module is configured to declare a potential atrial arrhythmia to be an atrial arrhythmia based on the hemodynamic performance determined from the ECI measurements. The hemodynamic performance assessment module is further enabled to compare a current ECI pattern with a prior baseline ECI waveform.

Abstract: In an implantable heart monitoring device and method, particularly for monitoring diastolic dysfunction, a control circuit (a) detects the heart rate, (b) derives information correlated to the stroke volume of the heart at the detected heart rate, and (c) stores the detected heart rate and the derived information correlated to the stroke volume in a memory. The control circuit automatically implements (a), (b) and (c) at a number of different occasions for a number of different, naturally varying heart rates, so that the memory contains information indicating the stroke volume as a function of the heart rate.

Abstract: A method for ‘ruling out’ acute myocardial infarction (AMI) in a subject presenting with chest pain expected to be cardiac in nature. The method includes a) recording an Electrocardiography (ECG) reading from said subject, b) determining the amount of Heart-type Fatty acid binding protein (H-FABP) and cardiac Troponin T (cTnT) in a sample from said subject, c) comparing the results from b) to reference values for ruling out an acute Myocardial Infarction in a subject, and d) based on the results from steps a)-c) either ‘ruling out’ or ‘ruling in’ a diagnosis of acute Myocardial Infarction in said subject.

Abstract: The present invention provides systems, methods and computer program products for monitoring a heart. According to one embodiment, the system includes an implantable registering unit. The registering unit comprises a first controller structured to register an electrical signal from the heart. The system includes a second controller in operable communication with the first controller. The second controller comprises a data repository structured to receive data corresponding to the registered electrical signal and being structured to store the data. The data repository stores data corresponding to a baseline electrical signal of the heart. The second controller is structured to receive the data from the first controller corresponding to the registered electrical signal and to compare the registered electrical signal to the baseline electrical signal to determine whether the heart is functioning properly.

Abstract: A method, including inserting a flexible probe into a living subject and positioning a distal end of the probe in a heart of the subject, the distal end including a position sensor configured to generate position signals indicative of a position of the distal end, and an electrode configured to convey electrical signals from the heart. The method further includes formulating, in response to the position signals, a first indication of a change in a mean position of the heart within the living subject and deriving a second indication of a change in the electrical signals. The method also includes determining, in response to the first and second indications, a new mean position of the heart.

Abstract: Though mechanocardiogram is considered to have a high medical value, mechanocardiogram recording device is large in size and very expensive, obtained data lacks reliability, a measurement algorithm has not been settled, use of an apexcardiogram for diagnosis is not useful for diagnosis of the circulatory system, and there has been no measuring equipment capable of measuring pexcardiogram which contribute to determination of heal condition of a living body to be measured. For measurement of heartbeat of a living body, measuring device which allows simple measurement of apexcardiogram at bedside has been developed using a pressure sensor and/or wave sensor capable of measuring change in pressure at multiple portions adjacent to one another, and simple electronic circuit.

Abstract: The present invention comprises a cardiopulmonary resuscitation (CPR) feedback device and a method for performing CPR. A chest compression detector device is provided that measures chest compression during the administration of CPR. The chest compression detector device comprises a signal transmitter operably positioned on the chest of the patient and adapted to broadcast a signal, and a signal receiver adapted to receive the signal. The chest compression detector device also comprises a processor, operably connected to the signal transmitter and the signal receiver. The processor repeatedly analyzes the signal received to determine from the signal a series of measurements of compression of the chest, and feedback is provided to the rescuer based on the series of measurements.

Abstract: While analyzing ventricular repolarization in accordance with the invention, ECG measurement with excitation of heart rate is evaluated and the coupling of an internal parameter, for example QT to heartbeat interval, for example RR, is modeled by a transfer function with three parameters. The values of the resulting five parameters describing the static and dynamic characteristics of ventricular repolarization are obtained by means of transfer function parameters and the measured values of heart rate and the internal parameter. The effect of medication is evaluated from the difference of the values of these parameters determined before and after administrating the medication.

Abstract: The disclosed embodiments include a method, system, and device for conducting ultrasound interrogation of a medium. The novel method includes transmitting a non-beamformed or beamformed ultrasound wave into the medium, receiving more than one echoed ultrasound wave from the medium, and converting the received echoed ultrasound wave into digital data. The novel method may further transmit the digital data. In some embodiments, the transmitting may be wireless. The novel device may include transducer elements, an analog-to-digital converter in communication with the transducer elements, and a transmitter in communication with the analog-to-digital converter. The transducers may operate to convert a first electrical energy into an ultrasound wave. The first electrical energy may or may not be beamformed. The transducers also may convert an echoed ultrasound wave into a second electrical energy.

Abstract: Techniques are provided for assessing left atrial pressure (LAP) based on atrial electrocardiac signal parameters, particularly intra-atrial conduction delay (IACD) and P-wave duration. In one example, a pacemaker or other implantable device senses an intracardiac electrogram (IEGM) or a subcutaneous electrocardiogram (ECG), from which IACD and P-wave duration are derived. The device tracks changes, if any, in the parameters. A significant increase in either IACD or P-wave duration is associated with an increase in LAP. In some examples, conversion factors are calibrated for use with a particular patient to relate IACD and/or P-wave duration values to LAP values to provide an estimate of actual LAP. The conversion factors are pre-calibrated using LAP measurements obtained using a wedge pressure sensor. In other examples, IACD and P-wave duration are instead used to confirm the detection of an elevation in LAP initially made using impedance signals. Other confirmation parameters are described as well.

Abstract: A method includes retrieving electrogram (EGM) data for N cardiac cycles from a memory of an implantable medical device. N is an integer greater than 1. The method further include categorizing each of the N cardiac cycles into one of a plurality of categories based on a morphology of the N cardiac cycles and performing comparisons between pairs of the N cardiac cycles. Each of the comparisons between two cardiac cycles includes detecting a mismatch between the two cardiac cycles when the two cardiac cycles are in different categories, and detecting a match between the two cardiac cycles when the two cardiac cycles are in the same category. Additionally, the method includes classifying the rhythm of the N cardiac cycles based on a number of detected matches and detected mismatches.

Abstract: The invention provides a body-worn monitor that measures a patient's vital signs (e.g. blood pressure, SpO2, heart rate, respiratory rate, and temperature) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling). The body-worn monitor processes this information to minimize corruption of the vital signs by motion-related artifacts. A software framework generates alarms/alerts based on threshold values that are either preset or determined in real time. The framework additionally includes a series of ‘heuristic’ rules that take the patient's activity state and motion into account, and process the vital signs accordingly. These rules, for example, indicate that a walking patient is likely breathing and has a regular heart rate, even if their motion-corrupted vital signs suggest otherwise.

Abstract: Measured values of ST segment deviations obtained from a multi-lead ECG are transformed and displayed on a polar ST Circle Display, with zero ST deviation values located on a circle having a diameter that is greater than a maximum absolute ST segment deviation value obtained for any measured or derived lead. An ischemic condition and a location of the ischemia can thereby be easily determined.

Abstract: An external medical device can include a housing and a processor within the housing. The processor can be configured to receive an input signal for a patient receiving chest compressions from a mechanical chest compression device. The processor can also be configured to select at least one filter mechanism, the mechanical chest compression device having a chest compression frequency f. The processor can be further configured to apply the at least one filter mechanism to the signal to at least substantially remove chest compression artifacts from the signal, wherein the chest compression artifacts correspond to the chest compressions being delivered to the patient by the mechanical chest compression device, and wherein the at least one filter mechanism substantially rejects content in the frequency f plus content in at least one more frequency that is a higher harmonic to the frequency f.

Abstract: A cardiac rhythm management system provides for the trending of a third heart sound (S3) index. The S3 index is a ratio, or an estimate of the ratio, of the number of S3 beats to the number of all heart beats, where the S3 beats are each a heart beat during which an occurrence of S3 is detected. An implantable sensor such as an accelerometer or a microphone senses an acoustic signal indicative heart sounds including S3. An S3 detector detects occurrences of S3 from the acoustic signal. A heart sound processing system trends the S3 index on a periodic basis to allow continuous monitoring of the S3 activity level, which is indicative of conditions related to heart failure.

Abstract: A computer-based detection method employable with a sleeping subject for aiding in the differential-character diagnosis and treatments of apneic events includes gathering heart-sound data, including S1 data and S2 data. A combined time-frequency-intensity (TFI) analysis, of the gathered data is performed, in a continuous manner, over a selected time period. Based on the performing and the performed TFI analysis, an output is produced which is indicative of the presence and character of any detected apneic event.

Abstract: An apparatus for outputting heart sounds includes an implantable system and an external system. The implantable system includes a sensor for generating sensed signals representing detected heart sounds, an interface circuit and a control circuit for receiving the sensed signals, generating data representing the heart sounds therefrom, and transmitting the data to the external system via the interface circuit. The external system includes an interface circuit for communicating with the implantable system, and a control circuit for receiving the data representing the heart sounds and for generating control signals that cause an output device to generate outputs representing the sounds. The implantable system may also include a sensor(s) for detecting cardiac electrical signals. In this case, outputs representing the cardiac electrical signals are also output.

Abstract: A monitoring apparatus having a signal input for signals representing measurement values of one or more physiological parameters, and an evaluation and processing unit connected to the signal input. The evaluation and processing unit is designed to select, or differently weight, individual values from the values received for further processing based on one or more criteria such that measurement values raising doubts as to the validity thereof are not selected or given a very low weighting.

Abstract: Provided herein are implantable systems, and methods for use therewith, for monitoring a patient's pre-ejection interval (PEI). A signal indicative of cardiac electrical activity and a signal indicative of changes in arterial blood volume are obtained. One or more predetermined features of the signal indicative of cardiac electrical activity and the signal indicative of changes in arterial blood volume are detected. The patient's PEI is determined by determining an interval between the predetermined feature of the signal indicative of cardiac electrical activity and the predetermined feature of the signal indicative of changes in arterial blood volume.

Abstract: In order to reliably determine the left-ventricular ejection time TLVE of a heart of a subject, at least two different measuring methods are employed. This includes in any case the derivation of a first waveform related to thoracic electrical bioimpedance or bioadmittance. A second waveform can be determined by using pulse oximetry, Doppler velocimetry, measurement of arterial blood pressure and measurement of peripheral electrical bioimpedance or bioadmittance. Depending on signal quality, the results obtained by each method are weighted and then averaged. The weighted average for left-ventricular ejection time is used as an input variable for cardiovascular monitoring methods, which determine objective measurements of cardiovascular function and performance. Such measurements include, but are not limited to, left ventricular ejection fraction, stroke volume, cardiac output, systolic time ratio, and indices of ventricular contractility.

Abstract: State machine interface system, heart state machine analyzer and/or stimulator, comprising state machine algorithms and a graphical user interface, adapted to receive signals from a sensor device that are related to physiological activities of the heart and/or the circulatory system of a living being and the state machine algorithms determine states of heart cycles based upon the signals. The determined heart cycle states are graphically presented at the graphical user interface such that the temporal relation between the different states are illustrated. The graphical user interface may be circular diagrams or bar graphs including parts representing the temporal relation between the different states.

Abstract: A device for the analysis of an endocardiac signal of acceleration. The device preprocesses the acquired endocardiac acceleration (EA) signal by cutting the signal EA collected into sub-signals EA, each one have a duration of one cardiac cycle; separating the cut signals to isolate in each sub-signal EA at least one component EAx, associated with a major cardiac sound, and preferably into components EA1 and EA2 associated with the two major cardiac sounds S1 and S2; and performing a correlation on each component EA1 and EA2, to readjust each sub-signal in relation to a maximum of correlation, so as to deliver a readjusted component EA1 and a readjusted component EA2. The device further determines, starting from the isolated correlated components EA1 and EA2, a component average EA1 and a component average EA2, and to combine these components EA1 and average EA2 so as to produce an average global signal EA for one cycle.

Abstract: A living body state monitor apparatus includes: a living body information acquisition device to acquire living body information containing an electrocardiography waveform and a pulse waveform from a user; an irregular heartbeat detection section to detect an irregular heartbeat from the electrocardiography waveform; and a pulse wave feature quantity extraction section to extract a pulse wave feature quantity from a pulse wave corresponding to the irregular heartbeat. Further, a living body state determination section is included to determine a danger degree on user's living body state using both of (A) information on kind and/or continued time period of an irregular heartbeat detected by the irregular heartbeat detection section, and (B) a pulse wave feature quantity extracted by the pulse wave feature quantity extraction section, and/or a variation of the extracted pulse wave feature quantity.

Abstract: A device detects electrical and mechanical cardio-vascular activities of patient, especially early decompensation detection of congestive heart failure patients (CHF). The device includes a transmitter for transmitting electromagnetic signals of a predefined frequency into the chest of the patient, a Doppler radar sensor (1) for detecting a Doppler radar signal reflected in the patient's chest, and an ECG unit (3) for capturing an ECG signal of the patient's heart. This device allows for simultaneous detection of electrical and mechanical cardio-vascular activities of a patient which can be used in an easy and reliable way and which allows for implementation in a hand-held or wearable device.

Abstract: Apparatus and methods are described for imaging a portion of a body of a subject that undergoes a motion cycle. A plurality of image frames of the portion are acquired. The image frames are enhanced with respect to a first given feature of the image frames, by (a) image tracking the image frames with respect to the first given feature, (b) identifying a second given feature in each of the image frames, and (c) in response to the identifying, reducing visibility of the second given feature in the image frames. The image frames that (a) have been image tracked with respect to the first given feature, and (b) have had reduced therein the visibility of the second given feature, are displayed as a stream of image frames. Other embodiments are also described.

Abstract: A portable electronic device monitors the pulse or electrocardiogram of a person by integrated, attachable or wireless sensors. The portable device evaluates this data in real-time to assess heart rate variability coherence, and provide feedback through a variety of sounds and an array of LEDs. The feedback may be in the form of a breathing indicator or pacer usable as a respiratory cycle training system to indicate to the subject when the next breath should be taken. Such feedback may be correlated to the level of coherency the subject achieves. A coherence indicator may be used to provide the subject with real-time information relating to the level of coherence achieved.

Abstract: Techniques for reducing inappropriate tachyarrhythmia therapy and associated medical device systems are described. In some examples a processor is enabled to receive a cardiac electrical signal representative of electrical activity of a heart of a patient and provide an indication of cardiac electrical signal reliability. A heart sound analyzing module is enabled to receive the indication of cardiac electrical signal reliability and a heart sound signal representing sounds generated by the heart of the patient and generated by a heart sound sensor. The heart sound analyzing module selectively determines an ensemble averaged heart sound signal or detects a plurality of heart sounds from the heart sound signal in response to the indication of cardiac electrical signal reliability.

Abstract: A medical device system and method that includes receiving an A2 heart sound signal from a first external acoustic sensor, receiving a P2 heart sound signal from a second external acoustic sensor, determining at least one A2 heart sound signal parameter from the A2 heart sound signal, determining at least one P2 heart sound signal parameter from the P2 heart sound signal, and based on the at least one P2 heart sound signal parameter, estimating pulmonary arterial pressure.

Abstract: A method and device for detecting a cardiac event that includes sensing cardiac electrical signals representative of electrical activity of a heart of a patient, detecting the cardiac event in response to the sensed cardiac signals, determining an indication of signal reliability corresponding to the sensed cardiac signals as being one of a reliable signal and a not reliable signal, and switching operation of the device between a first mode of determining whether the sensed signal is one of treatable and not treatable and a second mode of determining whether the sensed signal is one of treatable and not treatable in response to the determined indication of signal reliability.

Abstract: Apparatus for automatically monitoring sleep, including a video recorder for recording live images of a subject sleeping, including a transmitter for transmitting the recorded images in real-time to a mobile device, and a computing device communicating with said transmitter, including a receiver for receiving the transmitted images in real-time, a processor for analyzing in real-time the received images and for automatically inferring in real-time information about the state of the subject, and a monitor for displaying in real-time the information inferred by said processor about the state of the subject. A method and a computer-readable storage medium are also described and claimed.

Abstract: The present invention relates to a device for examination and use of an electrical field in a magnetic gradient field, containing magnetic particles in an examination area of an object under examination. The invention also relates to a method of determining the, especially three-dimensional, conductivity distribution in an examination area of an object under examination using a device according to the invention, a method for drug or active ingredient release, especially in locally targeted manner, in an examination area of an object under examination likewise using a device according to the invention, as well as use of a device according to the invention for electro-stimulation.

Abstract: Provided are a somatic data-measuring apparatus that can easily and accurately measure the optimal exercise intensity for the subject being measured, and a somatic data measurement method.

Abstract: The invention provides a body-worn monitor featuring a processing system that receives a digital data stream from an ECG system. A cable houses the ECG system at one terminal end, and plugs into the processing system, which is worn on the patient's wrist like a conventional wristwatch. The ECG system features: i) a connecting portion connected to multiple electrodes worn by the patient; ii) a differential amplifier that receives electrical signals from each electrode and process them to generate an analog ECG waveform; iii) an analog-to-digital converter that converts the analog ECG waveform into a digital ECG waveform; and iv) a transceiver that transmits a digital data stream representing the digital ECG waveform (or information calculated from the waveform) through the cable and to the processing system. Different ECG systems, typically featuring three, five, or twelve electrodes, can be interchanged with one another.

Abstract: Embodiments relate to a heart monitor, which is connected to or can be connected to at least one sensor for pressure and volume data or equivalent substitute variables and which comprises an evaluation unit for processing at least one input signal reflecting the temporal course of pressure and volume data or equivalent substitute variables of the heart. The evaluation unit is configured such that it segments the input signal in accordance with individual completed cardiac cycles and examines segments of the input signal obtained in this way as to whether a particular segment of the input signal represents a PV diagram, which corresponds to specified quality conditions regarding the direction of circulation, morphology and distance between a starting and end values.

Abstract: The invention relates to a method and an apparatus for determining the systolic phase interval (SP) of an arterial pressure curve with a starting point (t0) of the systolic phase interval (SP) and an end point (tN) of the systolic phase interval (SP) wherein a QT interval is defined as the start of the Q wave and the end of the T wave in the hearts electrical cycle and wherein the determination of the end point (tN) of the systolic phase interval (SP) is restricted to the measured points of arterial pressure which fulfill the condition that the difference in time between the end point (tN) to be determined of the systolic phase interval (SP) and the starting point (t0) of the systolic phase interval (SP) is smaller than the QT interval.

Abstract: Techniques are provided for estimating left atrial pressure (LAP) or other cardiac performance parameters based on measured conduction delays. In particular, LAP is estimated based interventricular conduction delays. Predetermined conversion factors stored within the device are used to convert the various the conduction delays into LAP values or other appropriate cardiac performance parameters. The conversion factors may be, for example, slope and baseline values derived during an initial calibration procedure performed by an external system, such as an external programmer. In some examples, the slope and baseline values may be periodically re-calibrated by the implantable device itself. Techniques are also described for adaptively adjusting pacing parameters based on estimated LAP or other cardiac performance parameters. Still further, techniques are described for estimating conduction delays based on impedance or admittance values and for tracking heart failure therefrom.

Abstract: A cardiac rhythm management system provides for the trending of a third heart sound (S3) index. The S3 index is a ratio, or an estimate of the ratio, of the number of S3 beats to the number of all heart heats, where the S3 beats are each a heart beat during which an occurrence of S3 is detected. An implantable sensor such as an accelerometer or a microphone senses an acoustic signal indicative heart sounds including S3. An S3 detector detects occurrences of S3 from the acoustic signal. A heart sound processing system trends the S3 index on a periodic basis to allow continuous monitoring of the S3 activity level, which is indicative of conditions related to heart failure.

Abstract: Techniques are provided for estimating left atrial pressure (LAP) or other cardiac performance parameters based on measured conduction delays. In particular, LAP is estimated based interventricular conduction delays. Predetermined conversion factors stored within the device are used to convert the various the conduction delays into LAP values or other appropriate cardiac performance parameters. The conversion factors may be, for example, slope and baseline values derived during an initial calibration procedure performed by an external system, such as an external programmer. In some examples, the slope and baseline values may be periodically re-calibrated by the implantable device itself. Techniques are also described for adaptively adjusting pacing parameters based on estimated LAP or other cardiac performance parameters. Still further, techniques are described for estimating conduction delays based on impedance or admittance values and for tracking heart failure therefrom.

Abstract: Signal processing devices normally filter the signal to reduce noise. Any filtering is likely to eliminate useful components of the signal too. A device for and method of signal processing is disclosed, wherein intrinsically clean signal cycles are selected for reproduction so that the processed signal retains components of all frequencies. A system that uses the disclosed device and the method for processing periodic physiological signals is also disclosed.

Abstract: Methods for detecting parameters in cardiac output related waveforms are described. The methods include methods for detecting individual heart beat cycles in a cardiac output related waveform, methods for detecting an error in an assigned starting point for an individual heart beat cycle in a cardiac output related waveform, methods for detecting a dichrotic notch for an individual heart beat cycle in a cardiac output related waveform, and methods for detecting an error in an assigned dichrotic notch for an individual heart beat cycle in a cardiac output related waveform. The identification of these parameters is important for a clinician as these parameters form the basis for the calculation of many other cardiac output related parameters.

Abstract: In a method and device for positioning a linear array of electrodes mounted on a distal end section of an elongated flexible member in a patient's respiratory airways at the level of the patient's diaphragm, a length of the elongated flexible member pre-determined to position the linear array of electrodes at the level of the patient's diaphragm is inserted through the patient's respiratory airways. Signals representative of an electrical activity of the patient's diaphragm (EAdi) are detected through the electrodes of the linear array, a presence or absence of ECG signal components is detected in the EAdi signals, and the position of the linear array of electrodes in the patient's respiratory airways is detected in response to the presence or absence of the ECG signal components in the EAdi signals.

Abstract: A system and method for operating a security system include a device control module configured for electronic communication with a plurality of devices and a user interface coupled in electronic communication with the device control module. The user interface includes a voice memory and a first speaker. The user interface is configured to receive a first system event from the device control module identifying a first condition detected by the security system. The user interface is further configured to retrieve a voice message from the voice memory corresponding to the first system event and transmit the voice message via the first speaker.